Literature DB >> 8411392

Temperature-sensitive transforming mutants of the v-rel oncogene.

D W White1, T D Gilmore.   

Abstract

By making site-directed mutations in the avian retroviral oncogene v-rel, we created two temperature-sensitive (ts) transforming mutants; these changes were analogous to mutations previously shown to confer a ts function onto the Dorsal protein of Drosophila melanogaster. Chicken spleen cells infected with the ts v-rel mutants formed colonies in agar at 36.5 degrees C but not at 41.5 degrees C. In addition, spleen cells derived from the ts v-rel-transformed colonies could be propagated in liquid culture at 36.5 degrees C but rapidly senesced at 41.5 degrees C. Both mutant v-Rel proteins were also ts for DNA binding in vitro. These mutants may be valuable for identifying genes directly regulated by v-rel.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8411392      PMCID: PMC238136     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Oncogenic transformation by vrel requires an amino-terminal activation domain.

Authors:  J Kamens; P Richardson; G Mosialos; R Brent; T Gilmore
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

2.  Interaction of the v-rel protein with an NF-kappa B DNA binding site.

Authors:  N Kabrun; J W Hodgson; M Doemer; G Mak; B R Franza; P J Enrietto
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

3.  v-rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells.

Authors:  T D Gilmore; H M Temin
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

4.  Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transformation by REV-T.

Authors:  T D Gilmore; H M Temin
Journal:  Cell       Date:  1986-03-14       Impact factor: 41.582

5.  The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters.

Authors:  C Gélinas; H M Temin
Journal:  Oncogene       Date:  1988-10       Impact factor: 9.867

6.  The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.

Authors:  D W Ballard; W H Walker; S Doerre; P Sista; J A Molitor; E P Dixon; N J Peffer; M Hannink; W C Greene
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

7.  The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.

Authors:  S Sif; A J Capobianco; T D Gilmore
Journal:  Oncogene       Date:  1993-09       Impact factor: 9.867

Review 8.  NF-kappa B, KBF1, dorsal, and related matters.

Authors:  T D Gilmore
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

9.  Cloning and expression of a chicken c-rel cDNA: unlike p59v-rel, p68c-rel is a cytoplasmic protein in chicken embryo fibroblasts.

Authors:  A J Capobianco; D L Simmons; T D Gilmore
Journal:  Oncogene       Date:  1990-03       Impact factor: 9.867

10.  Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors.

Authors:  S Watanabe; H M Temin
Journal:  Mol Cell Biol       Date:  1983-12       Impact factor: 4.272

View more
  10 in total

1.  Role of Nr13 in regulation of programmed cell death in the bursa of Fabricius.

Authors:  R M Lee; G Gillet; J Burnside; S J Thomas; P Neiman
Journal:  Genes Dev       Date:  1999-03-15       Impact factor: 11.361

2.  Interaction of the v-Rel oncoprotein with NF-kappaB and IkappaB proteins: heterodimers of a transformation-defective v-Rel mutant and NF-2 are functional in vitro and in vivo.

Authors:  D W White; G A Pitoc; T D Gilmore
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

3.  Differential regulation of the inhibitor of apoptosis ch-IAP1 by v-rel and the proto-oncogene c-rel.

Authors:  Jarmila Kralova; Andrew S Liss; William Bargmann; Cullen Pendleton; Janani Varadarajan; Emin Ulug; Henry R Bose
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein.

Authors:  M You; P T Ku; R Hrdlicková; H R Bose
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

5.  NF-kappa B p100 is one of the high-molecular-weight proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.

Authors:  S Sif; T D Gilmore
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

6.  The relocalization of v-Rel from the nucleus to the cytoplasm coincides with induction of expression of Ikba and nfkb1 and stabilization of I kappa B-alpha.

Authors:  R Hrdlicková; J Nehyba; A Roy; E H Humphries; H R Bose
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

7.  LIM domain-containing protein trip6 can act as a coactivator for the v-Rel transcription factor.

Authors:  M K Zhao; Y Wang; K Murphy; J Yi; M C Beckerle; T D Gilmore
Journal:  Gene Expr       Date:  1999

8.  Mechanism of telomerase activation by v-Rel and its contribution to transformation.

Authors:  Radmila Hrdlicková; Jirí Nehyba; Andrew S Liss; Henry R Bose
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

9.  A mutant v-rel with increased ability to transform B lymphocytes.

Authors:  P Romero; E H Humphries
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

10.  Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered kappa B DNA-binding complexes in transformed cells.

Authors:  R Hrdlicková; J Nehyba; H R Bose
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.